Intron Retention of DDX39A Driven by SNRPD2 is a Crucial Splicing Axis for Oncogenic MYC/Spliceosome Program in Hepatocellular Carcinoma
Advanced Science · 2024
DOI: 10.1002/advs.202403387 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Cunjie Chang und 31 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy and Department of Hepatology, the Affiliated Hospital of Hangzhou Normal, University Hangzhou Normal University, Hangzhou, 311121,…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, DEAD-box RNA Helicases, Introns, Liver Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovative Research Group Project of the National Natural Science Foundation of China, National Natural Science Foundation of China, National Outstanding Youth Science Fund Project of National Natural Science Foundation of China.
Abstract (Originalsprache)
RNA splicing is a dynamic molecular process in response to environmental stimuli and is strictly regulated by the spliceosome. Sm proteins, constituents of the spliceosome, are key components that mediate splicing reactions; however, their potential role in hepatocellular carcinoma (HCC) is poorly understood. In the study, SNRPD2 (PD2) is found to be the most highly upregulated Sm protein in HCC and to act as an oncogene. PD2 modulates DDX39A intron retention together with HNRNPL to sustain the DDX39A short variant (39A_S) expression. Mechanistically, 39A_S can mediate MYC mRNA nuclear export to maintain high MYC protein expression, while MYC in turn potentiates PD2 transcription. Importantly, digitoxin can directly interact with PD2 and has a notable cancer‐suppressive effect on HCC. The study reveals a novel mechanism by which DDX39A senses oncogenic MYC signaling and undergoes splicing via PD2 to form a positive feedback loop in HCC, which can be targeted by digitoxin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy and Department of Hepatology, the Affiliated Hospital of Hangzhou Normal, University Hangzhou Normal University, Hangzhou, 311121, P. R. China.
- Medical Molecular Biology Laboratory, Medical College, Jinhua University of Vocational Technology, Jinhua, 321016, P.R. China.
- School of Public Health, Hangzhou Normal University, Hangzhou, 311121, P. R. China.
- Laboratory of Cancer Genomics, Division of Cellular and Molecular Research, National Cancer Centre, Singapore, 169610, Singapore.
- The First Affiliated Hospital, Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, Key Laboratory of Organ Transplantation of Zhejiang Province, School of Medicine, Zhejiang University, Ha…
- Hepatobiliary and Liver transplantation Department of Hainan Digestive Disease Center, The Second Affiliated Hospital of Hainan Medical University, Haikou, 570216, P. R. China.
ORCID-Profile: Qian Li, Jianxiang Chen
Förderung
- Innovative Research Group Project of the National Natural Science Foundation of China
- National Natural Science Foundation of China
- National Outstanding Youth Science Fund Project of National Natural Science Foundation of China
- "Pioneer" and "Leading Goose" R&D Program of Zhejiang Province
- Start-up Grant of HZNU
- the Key Project of Social Development of Jinhua Science and Technology Bureau of Zhejiang Province
- Fundamental Research Funds for the Central Universities
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Chang, C., Li, L., Su, L., Yang, F., Zha, Q., Sun, M., Tao, L., Wang, M., Song, K., Jiang, L., Gao, H., Liang, Y., Xu, C., Yong, C., Wang, M., Huang, J., Liu, J., Jin, W., Lv, W., …, & Chen, J. (2024). Intron Retention of DDX39A Driven by SNRPD2 is a Crucial Splicing Axis for Oncogenic MYC/Spliceosome Program in Hepatocellular Carcinoma. Advanced Science. https://doi.org/10.1002/advs.202403387
Vancouver
Chang C, Li L, Su L, Yang F, Zha Q, Sun M, et al. Intron Retention of DDX39A Driven by SNRPD2 is a Crucial Splicing Axis for Oncogenic MYC/Spliceosome Program in Hepatocellular Carcinoma. Advanced Science. 2024. doi:10.1002/advs.202403387
BibTeX
@article{Chang2024,
author = {Chang, Cunjie and Li, Lina and Su, Ling and Yang, Fan and Zha, Quanxiu and Sun, Mengqing and Tao, Lin and Wang, Menglan and Song, Kangli and Jiang, Liangyu and Gao, Haojin and Liang, Yexin and Xu, Chao and Yong, Caiyu and Wang, Minmin and Huang, Jiacheng and Liu, Jing and Jin, Weiwei and Lv, Wenyuan and Dong, Heng and Li, Qian and Bu, Fangtian and Yan, Shuanghong and Qi, Haoxiang and Zhao, Shujuan and Zhu, Yingshuang and Wang, Yu and Shi, Junping and Qiao, Yiting and Xu, Jian and Chabot, Benoit and Chen, Jianxiang},
title = {Intron Retention of DDX39A Driven by SNRPD2 is a Crucial Splicing Axis for Oncogenic MYC/Spliceosome Program in Hepatocellular Carcinoma},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202403387}
}
EUVIMED